Bg pattern

RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Rifamicina Adalvo 200 mg Modified Release Tablets

sodium rifamycin

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
    • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Rifamicina Adalvo and what is it used for
  2. What you need to know before taking Rifamicina Adalvo
  3. How to take Rifamicina Adalvo
  4. Possible side effects
  5. Storage of Rifamicina Adalvo
  6. Package Contents and Additional Information

1. What is Rifamicina Adalvo and what is it used for

Rifamicina Adalvo contains the active ingredient sodium rifamycin, an antibiotic that acts in the intestine. It is used to treat traveler's diarrhea that is accompanied by symptoms such as nausea, vomiting, flatulence, frequent urgent need to defecate, abdominal pain or intestinal colic in adults. Rifamicina Adalvo should not be used if the diarrhea is accompanied by fever or blood in the stool.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Rifamicina Adalvo

Do not takeRifamicina Adalvoif:

  • you are allergic to sodium rifamycin, similar types of antibiotics, or any of the other components of this medication (listed in section 6),
  • you have vomiting, abdominal pain, or constipation caused by intestinal obstruction,
  • you have a perforation, wound, or injury to the digestive system,
  • you have diarrhea with fever or blood in the stool.

Rifamicina Adalvo contains soy lecithin.

It should not be used in case of peanut or soy allergy.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Rifamicina Adalvo:

  • if your symptoms worsen during treatment,
  • if you do not feel better after three days of treatment,
  • if your symptoms recur shortly after stopping treatment.

A reddish discoloration of the urine may occur during treatment with this medication.

Consult your doctor if you experience symptoms such as frequent liquid diarrhea, abdominal pain, or intense intestinal colic, fever, or blood in the stool. This may be due to an infection (Clostridium difficile-associated diarrhea), which requires immediate medical attention.

If you are receiving treatment with a rifamycin antibiotic for a mycobacterial disease (e.g., tuberculosis), you should not take Rifamicina Adalvo.

Children and Adolescents

There is no experience with the use of Rifamicina Adalvo in children and adolescents.

Therefore, do not administer this medication to children and adolescents under 18 years of age.

Taking Rifamicina Adalvo with other medications

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

  • Rifamicina Adalvo should not be taken with similar types of antibiotics.
  • Tell your doctor if you are taking cyclosporine (an immunosuppressant), warfarin (an anticoagulant), or oral contraceptives.
  • If you take activated charcoal (e.g., to treat diarrhea), take Rifamicina Adalvo at least two hours after taking the activated charcoal.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Do not takeRifamicina Adalvo if you are pregnant or breastfeeding, unless your doctor advises you to do so.

Driving and Using Machines

It is unlikely that Rifamicina Adalvo will affect your ability to drive or use machines. Do not drive or use machines if you experience dizziness or fatigue after taking Rifamicina Adalvo.

Rifamicina Adalvo contains sodium

This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

3. How to take Rifamicina Adalvo

Follow the instructions for administration of this medication exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

The recommended daily dose for adults over 18 years is:

  • Two tablets in the morning and two tablets in the evening for three days.
  • Unless otherwise prescribed, the duration of treatment should notexceed three days. Consult your doctor if you do not feel better after three days.

Use in Children and Adolescents

Rifamicina Adalvo is not indicated for children and adolescents under 18 years of age.

How to take the tablets:

  • Take the tablets with a glass of water. Swallow them whole. Do not crush or chew them.
  • The tablets can be taken with or without food.

If you take moreRifamicina Adalvothan you should

Consult a doctor if you have accidentally taken a higher dose than recommended.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to takeRifamicina Adalvo

Do not take a double dose to make up for forgotten doses. Take the next dose as prescribed.

If you stop takingRifamicina Adalvo

The recommended duration of treatment is three days. Consult your doctor if your symptoms worsen during treatment or if you do not feel better after three days.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Common: may affect up to 1 in 10 people

  • Headache
  • Diarrhea

Uncommon: may affect up to 1 in 100 people

  • Loss of appetite
  • Anxiety
  • Dizziness
  • Intestinal colic and abdominal spasms, abdominal distension, pain in the upper abdominal region, pain on palpation of the abdomen, aphthous ulcers (in the mouth), constipation, frequent urgent need to defecate, dry mouth, dyspepsia, belching, flatulence, increased gastric acid in the stomach, nausea
  • Hair loss, increased sweating, night sweats, itching
  • Pain in muscles and joints, back pain, pain in the limbs and sides, muscle spasms and muscle weakness
  • Abnormal urine color, pain or difficulty urinating, decreased urine output
  • Weakness, chest pain, general feeling of being unwell, pain, fever
  • Changes in liver function parameters (elevated ALT), changes in blood (elevated creatinine and urea)

The following side effects have been reported with antibiotics similar to Rifamicina Adalvo and may also occur with this medication. The frequency of these side effects is currently unknown:

  • Bacterial infections (Clostridium infections), fungal infections
  • Abnormal blood test results (decreased platelet count)
  • Severe acute reactions to the medication (anaphylactic reactions), allergic reactions to the medication
  • Severe allergic reaction causing swelling of the face or throat, itchy rash, redness/roughness of the skin
  • Swelling of the ankles and/or legs due to fluid accumulation

Reporting Side Effects

If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's online platform: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Rifamicina Adalvo

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the carton and blister after EXP. The expiration date is the last day of the month indicated.

Do not store above 30°C.

Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition ofRifamicina Adalvo

  • The active ingredient is sodium rifamycin. Each modified-release tablet contains 200 mg of sodium rifamycin.
  • The other excipients are: ammonio methacrylate copolymer (type B), ascorbic acid (E300), glycerol distearate, soy lecithin (E322), magnesium stearate, mannitol, methacrylic acid-methyl methacrylate copolymer (1:2), macrogol 6000 (E1521), colloidal anhydrous silica (E551), talc, titanium dioxide (E171), triethyl citrate (E1505), yellow iron oxide (E172).

Appearance of the Product and Package Contents

Rifamicina Adalvo 200 mg modified-release tablets are yellow-brown elliptical tablets with the inscription "SV2" on one side.

They are available in blister packs containing 12 tablets.

Marketing Authorization Holder

Dr. Falk Pharma GmbH

Leinenweberstr. 5

79108 Freiburg

Germany

Email: [email protected]

Manufacturer

Cosmo S.p.A

Via C. Colombo, 1

20045, Lainate

Milan, Italy

Phone: +39 02 93 3371

Fax: +39 02 93 33 7663

Email: [email protected]

You can request more information about this medication from the local representative of the marketing authorization holder:

Dr. Falk Pharma España

Camino de la Zarzuela, 19

28023 Madrid

Spain

Phone: +34 91 3729508

This medication is authorized in the Member States of the European Economic Area under the following names:

Bulgaria, Denmark, Finland, Hungary, Norway, United Kingdom: Travyc

Spain, Greece, Sweden, Poland, Portugal: Rifamicina Adalvo

Germany: Gutivia

Date of the last revision of this package leaflet:05/2025.

Online doctors for RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS

Discuss questions about RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (94)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (130)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (38)
Doctor

Jorge Correa Bellido

General medicine 7 years exp.

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Camera Book a video appointment
€55
5.0 (1056)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS?
RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS?
The active ingredient in RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS is rifamycin. This information helps identify medicines with the same composition but different brand names.
Who manufactures RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS?
RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS is manufactured by Adalvo Competence Center S.R.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RIFAMPICIN ADALVO 200 mg MODIFIED-RELEASE TABLETS?
Other medicines with the same active substance (rifamycin) include DIFICLIR 200 mg FILM-COATED TABLETS, DIFICLIR 40 mg/ml ORAL SUSPENSION GRANULES, HUMATIN 250 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media